Why the study?
The Cardiac Metabolic Index is a comprehensive metabolic indicator, but studies evaluating its relationship with diabetic kidney disease are limited.
Does an elevated Cardiac Metabolic Index (CMI) associate with an increased risk of Diabetic Kidney Disease (DKD) in adults with Type 2 Diabetes Mellitus?
Does an elevated Cardiac Metabolic Index (CMI) associate with an increased risk of Diabetic Kidney Disease (DKD) in adults with Type 2 Diabetes Mellitus?
Elevated Cardiac Metabolic Index is independently associated with an increased risk of diabetic kidney disease in adults with type 2 diabetes, suggesting its potential utility as a low-cost screening tool.
CMI may mark higher DKD odds in NHANES adults; leaves open causality and utility pending prospective validation.
BACKGROUND: The Cardiac Metabolic Index (CMI) is a comprehensive metabolic indicator, but studies on its relationship with Diabetic Kidney Disease (DKD) are limited. We aim to explore the association between CMI and DKD. METHODS: We obtained participant-related data from the National Health and Nutrition Examination Survey (NHANES), including complete information on DKD, CMI, and other covariates. We employed weighted multivariable logistic regression models, restricted cubic spline (RCS) regression analysis, subgroup analyses, and interaction tests to explore the relationship between CMI and DKD. Additionally, we utilized receiver operating characteristic (ROC) curves to compare the performance of CMI in identifying DKD relative to a body shape index (ABSI), body roundness index (BRI), visceral adiposity index (VAI), and lipid accumulation product (LAP) indices. RESULTS: According to the logistic regression analysis, a positive correlation between CMI and DKD was observed among the 2371 participants included in the study (OR: 1.40, 95% CI: 1.19-1.66). RCS analysis indicated that this relationship is nonlinear. When CMI was converted from a continuous variable to quartiles, the prevalence of DKD in the highest quartile group showed a significant 84% increase compared to the lowest quartile group (OR: 1.84, 95% CI: 1.24-2.72). The area under the ROC curve of CMI for identifying DKD was 0.67, outperforming other indices. The results of subgroup analyses and interaction tests were stable. CONCLUSION: Elevated CMI is associated with an increased risk of DKD and can serve as a low-cost screening tool, allowing physicians to potentially identify high-risk diabetic patients early and implement timely interventions to slow the progression of DKD.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: